Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice

When encapsulated with alginate derivatives that resist the foreign-body response, human embryonic stem cell–derived beta cells restore long-term normoglycemia in immunocompetent mice without the need for immunosuppression.